The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
307 - With more 'digital detailing' from reps to physicians using iPads and tablets, many software platforms offer the ability to re-order slides in a presentation. As PAAB approves these materials do they approve them in the order reviewed only, or as individual slides / videos etc that can be re-ordered by a drug company without further approval?
Submission Requirements/process & Timelines/eFiles
1
Posts
1
Posters
288
Views
1
Watching
-
The slides are approved only in the order in which they have been reviewed. Preclearance is most effective as a regulatory mechanism when promotional tools are used in the precise way in which they were reviewed. Please refer to Q&A # 198 for a solution on how to leverage some of the functionality you are describing.
